List of Children's Allegra Allergy drug patents
Children'S Allegra Allergy is owned by Chattem Sanofi.
Children'S Allegra Allergy contains Fexofenadine Hydrochloride.
Children'S Allegra Allergy has a total of 1 drug patent out of which 0 drug patents have expired.
Children'S Allegra Allergy was authorised for market use on 24 January, 2011.
Children'S Allegra Allergy is available in suspension;oral dosage forms.
The generics of Children'S Allegra Allergy are possible to be released after 02 August, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8933097 | CHATTEM SANOFI | Fexofenadine suspension formulation |
Aug, 2030
(7 years from now) | |
Drugs and Companies using FEXOFENADINE HYDROCHLORIDE ingredient
Market Authorisation Date: 24 January, 2011
Treatment: NA
Dosage: SUSPENSION;ORAL
CHILDREN'S ALLEGRA ALLERGY family patents
3
United States
1
Israel
1
South Africa
1
Denmark
1
Austria
1
Australia
1
Egypt
1
Hong Kong
1
Slovenia
1
Jordan
1
Russia
1
Morocco
1
Uruguay
1
Norway
1
Costa Rica
1
Germany
1
Argentina
1
Brazil
1
Honduras
1
Croatia
1
Portugal
1
Cyprus
1
Malaysia
1
Spain
1
Dominican Republic
1
Korea, Republic of
1
Poland
1
Peru
1
RS
1
China
1
Taiwan, Province of China
1
Ecuador
1
Ukraine
1
Japan
1
Canada
1
Tunisia
1
New Zealand
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic